Sycrest sublingual tablets 5mg from Meiji Seika Pharma contain asenapine maleate, an atypical antipsychotic indicated for moderate to severe manic episodes associated with bipolar I disorder and for schizophrenia. It is administered as a sublingual tablet. The YJ code is 1179056F1021, with a standard of 5mg per tablet.
Sycrest sublingual tablets 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →